Note: Ingredients listed on restricted chemical lists
EC/CAS
1317-33-5
Name of the chemical
molybdenum disulphide
Concentration
N/A
EC/CAS
7632-00-0
Name of the chemical
Sodium nitrite
Concentration
N/A
General Information
Revision date
2005-07-31
Product name
ROYCO 49
Icons in SDS
Company Information
company name
MILSPEC
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
Physical state Semi-solid (grease). Odor : Slight. Color : Black. Hazard status This material is classified hazardous under OSHA regulations in the United States, the WHMIS Controlled Product Regulation in Canada, the NOM-018-STPS-2000 in Mexico and Brazil NBR 14725:2001. Emergency overview : WARNING! CANCER HAZARD. CONTAINS MATERIAL WHICH CAN CAUSE CANCER. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. Avoid contact with skin and clothing. Avoid breathing dust. Keep container closed. Use only with adequate ventilation. Wash thoroughly after handling. Risk of cancer depends on duration and level of exposure. This product contains a component which, in powdered form, may cause respiratory tract and eye irritation; however, since this component is incorporated into a grease, the risk of inhalation of is negligible, as is any possible cancer hazard associated with this material.
Principle Routes of Exposure
Skin contact. Eye contact. Ingestion.
Potential Acute Health Effects
Eyes Irritating to eyes. Skin Irritating to skin. Inhalation Irritating to respiratory system. Ingestion Practically non-toxic if swallowed.
Potential chronic health
Carcinogenic effects: Classified 1 (Known to be human carcinogens.) by NTP, + (Proven.) effects by NIOSH [Graphite]. Classified A2 (Suspected for humans.) by ACGIH, 2A (Probable for human.) by IARC [Graphite]. Mutagenic effects: Not available.
Teratogenic Effects
Not available Medical conditions Repeated skin exposure can produce local skin destruction or dermatitis. Repeated aggravated by over- exposure of the eyes to a low level of dust can produce eye irritation. exposure See toxicological information (section 11) 3 .